Clinical Study

Rtog-1308: Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy For Inoperable Stage II-IIIb Nsclc

Posted Date: Sep 28, 2020

  • Investigator: Emily Daugherty
  • Specialties: Cancer, Lung Cancer, Oncology, Pulmonary Diseases, Radiation Oncology
  • Type of Study: Device

To compare the overall survival (OS) in patients with stage II-IIIB NSCLC Photon (X-Ray) radiation therapy (Arm 1) versus Proton radiation therapy (Arm 2) both given with concurrent platinum-based chemotherapy


Newly Diagnosed Stage Ii To Stage Iiib Non-Small Cell Lung Cancer Which Is Not Surgically Removed


Proton Therapy, Lung Cancer, Radiation Therapy

For More Information:

Dr. Emily Daugherty, Md

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.